Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa
Fareed Abdullah, Jonathan E. Myers, Debashis Basu, et al.
International Journal of Infectious Diseases (2021) Vol. 116, pp. 38-42
Open Access | Times Cited: 390

Showing 1-25 of 390 citing articles:

Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study
Tommy Nyberg, Neil M. Ferguson, Sophie Nash, et al.
The Lancet (2022) Vol. 399, Iss. 10332, pp. 1303-1312
Open Access | Times Cited: 1164
Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
Sandile Cele, Laurelle Jackson, David S. Khoury, et al.
Nature (2021) Vol. 602, Iss. 7898, pp. 654-656
Open Access | Times Cited: 1091
SARS-CoV-2 Omicron variant: recent progress and future perspectives
Yao Fan, Xiang Li, Lei Zhang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 479
Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods — United States, December 2020–January 2022
A. Danielle Iuliano, Joan Brunkard, Tegan K. Boehmer, et al.
MMWR Morbidity and Mortality Weekly Report (2022) Vol. 71, Iss. 4, pp. 146-152
Open Access | Times Cited: 416
mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron
Matthew Gagné, Juan I. Moliva, Kathryn E. Foulds, et al.
Cell (2022) Vol. 185, Iss. 9, pp. 1556-1571.e18
Open Access | Times Cited: 213
Estimating disease severity of Omicron and Delta SARS-CoV-2 infections
Alex Sigal, Ron Milo, Waasila Jassat
Nature reviews. Immunology (2022) Vol. 22, Iss. 5, pp. 267-269
Open Access | Times Cited: 190
Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study
Peter Bager, Jan Wohlfahrt, Samir Bhatt, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 7, pp. 967-976
Open Access | Times Cited: 180
Comparison of Patients Infected With Delta Versus Omicron COVID-19 Variants Presenting to Paris Emergency Departments
Donia Bouzid, Benoît Visseaux, Christian Kassasseya, et al.
Annals of Internal Medicine (2022) Vol. 175, Iss. 6, pp. 831-837
Open Access | Times Cited: 178
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance — One Hospital, California, July 15–September 23, 2021, and December 21, 2021–January 27, 2022
Matthew Modes, Michael P. Directo, Michael Melgar, et al.
MMWR Morbidity and Mortality Weekly Report (2022) Vol. 71, Iss. 6, pp. 217-223
Open Access | Times Cited: 161
mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions
Paulina Kapłonek, Deniz Cizmeci, Stephanie Fischinger, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 645
Open Access | Times Cited: 124
COVID-19 2022 update: transition of the pandemic to the endemic phase
Michela Biancolella, Vito Luigi Colona, Ruty Mehrian‐Shai, et al.
Human Genomics (2022) Vol. 16, Iss. 1
Open Access | Times Cited: 120
Alpha to Omicron: Disease Severity and Clinical Outcomes of Major SARS-CoV-2 Variants
Frank Esper, Thamali M. Adhikari, Zheng Jin Tu, et al.
The Journal of Infectious Diseases (2022) Vol. 227, Iss. 3, pp. 344-352
Open Access | Times Cited: 119
Effectiveness of BNT162b2 Vaccine against Omicron in Children 5 to 11 Years of Age
Sharon Hui Xuan Tan, Alex R. Cook, Derrick Heng, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 6, pp. 525-532
Open Access | Times Cited: 115
Understanding the Role of SARS-CoV-2 ORF3a in Viral Pathogenesis and COVID-19
Jiantao Zhang, Amara Ejikemeuwa, Volodymyr Gerzanich, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 109
SARS-CoV-2 Omicron variant causes mild pathology in the upper and lower respiratory tract of hamsters
Federico Armando, Georg Beythien, Franziska Kaiser, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 97
Omicron SARS-CoV-2 variant of concern
Md Mohsin, Sultan Mahmud
Medicine (2022) Vol. 101, Iss. 19, pp. e29165-e29165
Open Access | Times Cited: 77
Characteristics of the first 1119 SARS‐CoV‐2 Omicron variant cases, in Marseille, France, November−December 2021
Linda Houhamdi, Philippe Gautret, Van Thuan Hoang, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 2290-2295
Open Access | Times Cited: 72
SARS-CoV-2 variants evolve convergent strategies to remodel the host response
Mehdi Bouhaddou, Ann‐Kathrin Reuschl, Benjamin J. Polacco, et al.
Cell (2023) Vol. 186, Iss. 21, pp. 4597-4614.e26
Open Access | Times Cited: 69
Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019–positive patients
Feihong Hu, Yijie Jia, Dan‐Yan Zhao, et al.
Clinical Microbiology and Infection (2023) Vol. 29, Iss. 7, pp. 835-844
Open Access | Times Cited: 64
Severity of the Omicron SARS‐CoV‐2 variant compared with the previous lineages: A systematic review
Maryam Arabi, Yousef Al‐Najjar, Nada Mhaimeed, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 11, pp. 1443-1464
Open Access | Times Cited: 59
Severity and outcomes of Omicron variant of SARS-CoV-2 compared to Delta variant and severity of Omicron sublineages: a systematic review and metanalysis
Pryanka Relan, Nkengafac Villyen Motaze, Kavita Kothari, et al.
BMJ Global Health (2023) Vol. 8, Iss. 7, pp. e012328-e012328
Open Access | Times Cited: 57
Hospital Outcomes of Community-Acquired SARS-CoV-2 Omicron Variant Infection Compared With Influenza Infection in Switzerland
Lea Portmann, Marlieke E.A. de Kraker, Georg Fröhlich, et al.
JAMA Network Open (2023) Vol. 6, Iss. 2, pp. e2255599-e2255599
Open Access | Times Cited: 42
Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
Sandile Cele, Laurelle Jackson, David S. Khoury, et al.
Nature (2021)
Open Access | Times Cited: 102
Timing of elective surgery and risk assessment after SARS‐CoV‐2 infection: an update
Kariem El‐Boghdadly, Tim Cook, Tim Goodacre, et al.
Anaesthesia (2022) Vol. 77, Iss. 5, pp. 580-587
Open Access | Times Cited: 67
Clinical Severity of SARS-CoV-2 Omicron Variant Compared with Delta among Hospitalized COVID-19 Patients in Belgium during Autumn and Winter Season 2021–2022
Nina Van Goethem, Pui Yan Jenny Chung, Marjan Meurisse, et al.
Viruses (2022) Vol. 14, Iss. 6, pp. 1297-1297
Open Access | Times Cited: 64
Page 1 - Next Page

Scroll to top